Diamond Biopharm is one of very few European regulatory companies which has experience in clinical and regulatory development programmes within the gene therapy sector, to an advanced stage of development. Its first European Marketing Authorisation Application submission for a gene therapy product will be in 2009.
Department of Health and Ageing (DHA)
The Department of Health and Ageing has a diverse set of responsibilities, but throughout there is a common purpose, which is reflected in our Vision statement: Better health and active ageing for all Australians. We aim to achieve our Vision through strengthening evidence-based policy advising, improving program management, research, regulation and partnerships with other government agencies, consumers and stakeholders.
Roberts Biosolutions Ltd
Hillcoat Place, Edinburgh
United Kingdom
Email: info@genetherapyreview.com
Twitter: @gentherev
